Mariner, LLC Jazz Pharmaceuticals PLC Transaction History

Mariner, LLC

$55.8 Billion
Q3 2024

A detailed history of Mariner, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Mariner, LLC holds 20,021 shares of JAZZ stock, worth $2.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,021

Previous 18,712 7.0%

Holding current value

$2.51 Million

Previous $2 Million 11.72%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$100.57 - $116.37 $131,646 - $152,328	1,309 Added 7.0%	20,021 $2.23 Million
Q2 2024 Aug 13, 2024	BUY	$103.94 - $118.98 $1.11 Million - $1.27 Million	10,642 Added 131.87%	18,712 $2 Million
Q1 2024 May 15, 2024	BUY	$115.19 - $132.77 $203,540 - $234,604	1,767 Added 28.03%	8,070 $971,000
Q4 2023 Feb 14, 2024	SELL	$114.26 - $136.0 $198,126 - $235,824	-1,734 Reduced 21.58%	6,303 $775,000
Q3 2023 Nov 13, 2023	BUY	$122.0 - $145.31 $92,354 - $109,999	757 Added 10.4%	8,037 $1.04 Million
Q2 2023 Aug 11, 2023	BUY	$122.5 - $147.16 $32,095 - $38,555	262 Added 3.73%	7,280 $902,000
Q1 2023 May 12, 2023	BUY	$133.98 - $160.47 $108,925 - $130,462	813 Added 13.1%	7,018 $1.03 Million
Q4 2022 Feb 14, 2023	BUY	$129.72 - $159.85 $65,508 - $80,724	505 Added 8.86%	6,205 $988,000
Q3 2022 Nov 10, 2022	BUY	$126.59 - $161.18 $721,563 - $918,726	5,700 New	5,700 $760,000
Q3 2019 Nov 13, 2019	SELL	$125.18 - $143.24 $209,426 - $239,640	-1,673 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$125.55 - $144.48 $2,385 - $2,745	19 Added 1.15%	1,673 $239,000
Q1 2019 May 15, 2019	BUY	$121.81 - $142.95 $201,473 - $236,439	1,654 New	1,654 $236,000

Others Institutions Holding JAZZ

# of Institutions

513

Shares Held

57.7M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.85B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account